Elagolix Completed Phase 2 Trials for Endometriosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00437658Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis
NCT00797225Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in Endometriosis